focus -WSS

focus

author：knowledge 2025-10-01 00:47:31 - browse：6

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Study: AI not yet building 'n

WSS

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Lasker Awards 2023: Winners in biomedical research

Telehealth startups turn to complex chronic diseases

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Telehealth startups turn to complex chronic diseases

Intarcia’s device

hotspot

focus

explore

Anesthesiologist group: stop taking Ozempic before surgery

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Hepatitis C has a cure — but many Americans still lack access to it

Brain worms: The science behind RFK Jr.'s parasitic infection

Medical records are filled with copy

Changes to biosimilar regulatory framework must prioritize patients

Walensky prepares to leave CDC — and Congress — behind

Biotech stock slump in 2023: awaiting the turnaround

Guidelines to prevent youth baseball injuries need more muscle

Shionogi licenses Pompe disease therapy from Maze Therapeutics

entertainment

Changes to biosimilar regulatory framework must prioritize patients

After gene therapy, two congenitally deaf children hear for the first time

It's been 20 years since Dolly the sheep. Where's my clone?

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Dairy farmers resist CDC push for PPE against bird flu virus

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

entertainment

explore

focus

focus